ANTIDOTE TREATMENT - NERVE AGENT
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded MERIDIAN MEDICAL TECHNOLOGIES, LLC a contract valued at $20,058,500.00 for the supply of an antidote treatment for nerve agent exposure, identified by NSN 6505013627427 and PR 7017576716. This contract, issued under the broader delivery order SPE2DP26D0001, was awarded on July 22, 2026, as part of a federal procurement process managed through the DIBBS system. The award is classified as a federal procurement with no specified set-aside or NAICS code, and the performance location is not detailed beyond the United States. The contract supports critical medical preparedness for the Department of Defense by ensuring the availability of life-saving countermeasures against nerve agent threats.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(2)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
